Intercept Pharmaceuticals

Intercept Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of therapeutics to treat progressive non-viral liver diseases in the United States, Europe, and Canada.

Morgan Prestwich were retained under Master Service Agreement (MSA) to build their entire International Operations (130 positions in 18months).

Above country appointments:
- VP's Market Access, Marketing, Medical
- Director's Market Access, Marketing, Medical- Snr Director Market Access
- Medical Directors
- Government Affairs
- Finance

In-country appointments:
GM's, Marketing, Medical, Market Access, KAM's in:
- Germany
- UK
- Italy
- France
- Spain
- Netherlands
- Sweden